Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ATLAS (A Transseptal Left Atrial System for Treatment of Mitral Regurgitation) Pivotal Trial

NCT06465745 is registered in ClinicalTrials.gov with 4C Medical Technologies, Inc. as lead sponsor.

NCT NCT06465745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06465745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ATLAS (A Transseptal Left Atrial System for Treatment of Mitral Regurgitation) Pivotal Trial
Lead sponsor
4C Medical Technologies, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
September 3, 2024
Completion date
September 30, 2031
Enrollment
450 (estimated)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

mitral incompetence, mitral insufficiency, mitral regurgitation, mitral valve incompetence, mitral valve regurgitation